Sign in
4

Changes in Ownership

HCW Biologics Inc. Filed Acc 0001209191-23-035581

Chief Financial Officer bought 24,696 shares at an average $2.07 ($51,020)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Byam Rebecca Chief Financial Officer 2023-06-07 Purchase +20,000 $2.03 $40,632 519,250 D
Byam Rebecca Chief Financial Officer 2023-06-08 Purchase +4,696 $2.21 $10,388 523,946 D
Open-market purchases · 24,696 sh · avg $2.07 · $51,020
Loading xslF345X04/doc4.xml…